StockData
Oncolytics Biotech Inc logo

Oncolytics Biotech Inc (ONCY) stock

ONCYNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 0/30
$0.38+0.04 (+12.53%)

Close on Nov 17, 2026Market cap $48.77MP/E –Yield –

Oncolytics Biotech cash

Cash and short-term investments held at the end of each period.

Oncolytics Biotech's cash was C$15.94M at Dec 31, 2024. For fiscal 2024 it was C$15.94M, down 54.3% from the year before. Over ten years it grew 1.2% a year on average. The highest annual figure on record is C$41.26M in fiscal 2021.

Annual cash

PeriodPeriod endValueChange
FY2024Dec 31, 2024C$15.94M-54.3%
FY2023Dec 31, 2023C$34.91M+199.3%
FY2022Dec 31, 2022C$11.67M-71.7%
FY2021Dec 31, 2021C$41.26M+32.2%
FY2020Dec 31, 2020C$31.22M+120.7%
FY2019Dec 31, 2019C$14.15M+3.3%
FY2018Dec 31, 2018C$13.70M+15.7%
FY2017Dec 31, 2017C$11.84M-1.6%
FY2016Dec 31, 2016C$12.03M-49.9%
FY2015Dec 31, 2015C$24.02M+69.7%
FY2014Dec 31, 2014C$14.15M–

Quarterly cash

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2024Dec 31, 2024C$15.94M-48.9%
Q4 FY2023Dec 31, 2023C$34.91M+146.8%
Q4 FY2022Dec 31, 2022C$11.67M-14.8%
Q4 FY2021Dec 31, 2021C$41.26M+248.6%
Q4 FY2020Dec 31, 2020C$31.22M+159.4%
Q4 FY2019Dec 31, 2019C$14.15M-41.1%
Q4 FY2018Dec 31, 2018C$13.70M-3.2%
Q4 FY2017Dec 31, 2017C$11.84M–
Q4 FY2016Dec 31, 2016C$12.03M–
Q4 FY2015Dec 31, 2015C$24.02M–
Q4 FY2014Dec 31, 2014C$14.15M–

More Oncolytics Biotech figures

See a number that looks wrong?